Quest Diagnostics ( DGX ), a prominent player in the field of diagnostic testing, recently received the U.S. Food and Drug Administration’s (“FDA”) 510(k) clearance for its Simplexa
Continue reading here:
Quest’s Simplexa Passes FDA Test – Analyst Blog